glp 1 bad GLP-1 for Prevention: Using Drugs Like Zepbound for Pre-Diabetes or Metabolic Risk -What Does Research Say? GLP-1s: Good or Bad?

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

Learn how to perform a GLP-1 and peptide injection safely with our step-by-step guide

What's inside each capsule

It's a fillip for new Novo Nordisk chief executive Mike Doustdar, who took the helm last year with a clear remit to defend the GLP-1-based weight loss and diabetes business from rivals like Eli Lilly, as well as knock-off versions of semaglutide that sidestep the company's intellectual property (IP).